glp 1 epilepsy A preliminary study of people with diabetes suggests that use of glucose-lowering GLP-1 drugs may be linked to a lower risk of developing epilepsy. The study was published on December 10, 2025 GLP-1 Agonists and DPP-4 Inhibitors

Chronic exposure to high glucose in intestinal organoids impairs the expression of transcription factors related to the differentiation of early and late endocrine progenitors and L-cell development including Ngn3 and Neurod1

Potential Side Effects and Considerations Though GLP-1 drugs offer exciting potential, they also come with side effects to consider, including: Nausea or vomiting Gastrointestinal upset Potential risk of pancreatitis Mood changes or fatigue in some users Because these medications act on complex systems within the brain and body, you should only use them under close supervision from a qualified medical provider

For anti-aging and skin rejuvenation, peptides like thymosin beta-4 and GHK-Cu stimulate collagen production, reduce wrinkles, and improve skin elasticity

Endocr Rev1999 Feb;20(1):68-100